Nadav Kidron
Nadav Kidron, Esq
Chief Executive Officer, President & Director

Mr. Kidron serves as Chief Executive Officer & Director of Oramed Pharmaceuticals, which he co-founded in 2006.

Mr. Kidron is an entrepreneur whose experience includes senior executive roles in a wide range of industries.

He co-founded Entera Bio as a joint venture formed by Oramed and DNA Biomedical Solutions. He is a member of the IATI Board, and an international lecturer on Israel’s entrepreneurial culture and the country’s roots as an oasis of innovative ideas.

He holds a bachelor’s degree in law and an international master’s in business administration, both from Bar-Ilan University in Israel. Mr. Kidron is a fellow of the Merage Business Executive Leadership Program and a member of the Israeli Bar Association.

Miriam Kidron, Ph.D
Chief Scientific Officer & Director

Dr. Kidron serves as Chief Scientific Officer and Director of Oramed Pharmaceuticals, which she co-founded in 2006.

Dr. Kidron is a pharmacologist and biochemist, who earned her PhD in biochemistry from the Hebrew University of Jerusalem.

For close to 20 years, Dr. Kidron has been a senior researcher in the Diabetes Unit at Hadassah-Hebrew University Medical Center in Jerusalem, Israel, earning the Bern Schlanger Award for her work on diabetes research.

She was formerly a visiting professor at the Medical School at the University of Toronto and is a member of the American, European and Israeli Diabetes Associations.

Josh Hexter
Chief Operating and Business Officer

Mr. Hexter serves as Chief Operating and Business Officer of Oramed Pharmaceuticals.  Mr. Hexter has nearly two decades of prominent leadership, business development and operations know-how, entrepreneurialism and management experience in the life science sector.

Prior to his current position, Mr. Hexter was Chief Business Officer of BrainsWay Ltd. (NASDAQ/TASE: BWAY).  Previously, he served as the Chief Operating Officer of Oramed.  Mr. Hexter has also served as Executive Director of Corporate In-Licensing at BioLineRx (NASDAQ/TASE: BLRX) and in the private equity and venture capital sector where he served as CEO of a VC-backed start-up.  As founder and CEO of Biosensor Systems Design, Mr. Hexter was instrumental in shaping the company’s strategic focus and in forging strategic agreements with Fortune 100 companies in the areas of food safety, medical diagnostics and homeland security.

Mr. Hexter earned a bachelor’s degree from the University of Wisconsin and a master’s degree in management from Boston University.

Avi Gabay, CFO
Chief Financial Officer

Mr. Gabay serves as Chief Financial Officer of Oramed Pharmaceuticals. He joined Oramed in 2019. Prior to his appointment, from 2015 until 2019, Mr. Gabay served as a corporate controller at Orcam Technologies Ltd. Previously, he provided economic services in the advisory department of KPMG Israel, a certified public accounting firm and worked in the tax department of the law firm, Gornitzky & Co.

Mr. Gabay holds a bachelor’s degree in law and accounting from Tel-Aviv University and is a certified public accountant in Israel and a member of the Israeli Bar Association.